EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Outcomes in intraductal papillary mucinous neoplasm‐derived pancreatic cancer differ from PanIN‐derived pancreatic cancer

Joseph R Habib iD, Ingmar F Rompen, Ammar A Javed, Mahip Grewal, Benedict Kinny-Köster, Paul C M Andel, D Brock Hewitt, Greg D Sacks, Marc G Besselink, Hjalmar C van Santvoort, Lois A Daamen, Martin Loos und 4 weitere

Journal of Gastroenterology and Hepatology · 2024

DOI: 10.1111/jgh.16686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Joseph R Habib und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, New York University Langone Health, New York, New York, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Adenocarcinoma, Mucinous. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Intraductal papillary mucinous neoplasm (IPMN)‐derived pancreatic ductal adenocarcinoma (PDAC) management is generally extrapolated from pancreatic intraepithelial neoplasia (PanIN)‐derived PDAC guidelines. However, these are biologically divergent, and heterogeneity further exists between tubular and colloid subtypes.

Methods

Consecutive upfront surgery patients with PanIN‐derived and IPMN‐derived PDAC were retrospectively identified from international centers (2000–2019). One‐to‐one propensity score matching for clinicopathologic factors generated three cohorts: IPMN‐derived versus PanIN‐derived PDAC, tubular IPMN‐derived versus PanIN‐derived PDAC, and tubular versus colloid IPMN‐derived PDAC. Overall survival (OS) was compared using Kaplan–Meier and log‐rank tests. Multivariable Cox regression determined corresponding hazard ratios (HR) and 95% confidence intervals (95% CI).

Results

The median OS (mOS) in 2350 PanIN‐derived and 700 IPMN‐derived PDAC patients was 23.0 and 43.1 months ( P < 0.001), respectively. PanIN‐derived PDAC had worse T‐stage, CA19‐9, grade, and nodal status. Tubular subtype had worse T‐stage, CA19‐9, grade, nodal status, and R1 margins, with a mOS of 33.7 versus 94.1 months ( P < 0.001) in colloid. Matched ( n = 495), PanIN‐derived and IPMN‐derived PDAC had mOSs of 30.6 and 42.8 months ( P < 0.001), respectively. In matched ( n = 341) PanIN‐derived and tubular IPMN‐derived PDAC, mOS remained poorer (27.7 vs 37.4, P < 0.001). Matched tubular and colloid cancers ( n = 112) had similar OS ( P = 0.55). On multivariable Cox regression, PanIN‐derived PDAC was associated with worse OS than IPMN‐derived (HR: 1.66, 95% CI: 1.44–1.90) and tubular IPMN‐derived (HR: 1.53, 95% CI: 1.32–1.77) PDAC. Colloid and tubular subtype was not associated with OS ( P = 0.16).

Conclusions

PanIN‐derived PDAC has worse survival than IPMN‐derived PDAC supporting distinct outcomes. Although more indolent, colloid IPMN‐derived PDAC has similar survival to tubular after risk adjustment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalAdenocarcinoma, MucinousHumansMaleFemaleAgedMiddle AgedRetrospective StudiesPancreatic Intraductal NeoplasmsNeoplasm StagingSurvival RateCarcinoma in Situ

Stichwörter der Autor:innen

colloidintraductal papillary mucinous neoplasminvasive IPMNpancreatic cancerpancreatic cystpancreatic neoplasmstubular

Autor:innen und Institutionen

  • Department of Surgery, New York University Langone Health, New York, New York, USA.
  • Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St. Antonius Hospital Nieuwegein, Utrecht, The Netherlands.
  • Heidelberg University Hospital, Heidelberg, Germany.
  • Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
  • Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.

ORCID-Profile: Joseph R Habib

Zitieren

APA

Habib, J. R., Rompen, I. F., Javed, A. A., Grewal, M., Kinny-Köster, B., Andel, P. C. M., Hewitt, D. B., Sacks, G. D., Besselink, M. G., van Santvoort, H. C., Daamen, L. A., Loos, M., He, J., Büchler, M. W., Wolfgang, C. L., & Molenaar, I. Q. (2024). Outcomes in intraductal papillary mucinous neoplasm‐derived pancreatic cancer differ from PanIN‐derived pancreatic cancer. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16686

Vancouver

Habib JR, Rompen IF, Javed AA, Grewal M, Kinny-Köster B, Andel PCM, et al. Outcomes in intraductal papillary mucinous neoplasm‐derived pancreatic cancer differ from PanIN‐derived pancreatic cancer. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16686

BibTeX
@article{Habib2024,
  author = {Habib, Joseph R and Rompen, Ingmar F and Javed, Ammar A and Grewal, Mahip and Kinny-Köster, Benedict and Andel, Paul C M and Hewitt, D Brock and Sacks, Greg D and Besselink, Marc G and van Santvoort, Hjalmar C and Daamen, Lois A and Loos, Martin and He, Jin and Büchler, Markus W and Wolfgang, Christopher L and Molenaar, I Quintus},
  title = {Outcomes in intraductal papillary mucinous neoplasm‐derived pancreatic cancer differ from PanIN‐derived pancreatic cancer},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1111/jgh.16686}
}
Kostenlos starten →